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Abstract Centromere autoantibodies are commonly found in
the serum of patients with some systemic autoimmune diseases.
Previous studies have shown that a major human centromere
autoantigen is the histone H3-like protein CENP-A. Although
the human cDNA has been cloned, native CENP-A has been
neither isolated nor expressed in Escherichia coli, and specific
antibodies to this chromatin-associated centromere protein are
not available yet. In this report, a highly charged peptide on
CENP-A (residues 3^17) was used to generate a monospecific
antibody that reacts by immunoblots with the 17 kDa
centromeric protein. Immunofluorescence analysis showed re-
activity of this anti-CENP-A serum in several but not all
mammalian culture cells analyzed, suggesting that the sequence
of this histone-like centromere protein could be more variable
throughout evolution than originally thought. Selective extrac-
tions of human placenta nuclear proteins and immunoblot
analysis indicated that CENP-A behaves in a similar way to
the core histone polypeptides after nuclease digestion of
chromatin. Also, immunoblot analysis demonstrated that the
CENP-A peptide used as immunogen is a target region on the
CENP-A molecule in several but not all CREST patients
analyzed with high titers of autoantibodies to the centromere.
Lastly, we found that in Jurkat cells induced to apoptosis,
CENP-A remains associated with the centromere, in contrast to
other human autoantigens studied during apoptosis.
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1. Introduction
The discovery of centromere-speci¢c autoantibodies in pa-
tients with limited systemic sclerosis (CREST syndrome) and
the characterization of the antigens recognized by these sera
have provided tools for the analysis of centromere structure
and function in mammalian cells [1^4]. Three major antigens,
the centromere proteins CENP-A, CENP-B and CENP-C,
were initially identi¢ed, with CENP-B being the centromere
autoantigen best characterized so far. CENP-B is a 80 kDa
protein that has been cloned in human [5], mouse [6] and
hamster [7]. It is located in the central domain of the centro-
mere, where the protein binds to a subset of the alphoid
satellite DNA that comprises the major DNA component of
the human centromere, and may play a role in the higher
order folding of alphoid chromatin through self-assembly
[8]. However, several reports have presented evidence both
for and against a direct role of CENP-B in centromere func-
tion [9]. On the other hand, CENP-C is a highly basic 140
kDa protein that has been cloned in human [10], mouse [11]
and sheep [12]. It is located in the inner kinetochore plate,
playing a critical role in the assembly of the kinetochore.
Several classes of antibodies produced in vitro have contrib-
uted to the speci¢c analysis of the putative function of the
centromeric proteins CENP-B and CENP-C, in studies such
as microinjection of cell cultures. In addition, CENP-A is a 17
kDa protein that has only been cloned in human, although
evidence for its expression and putative binding to the cen-
tromere of other mammalian cells has been presented [13,14].
CENP-A shares a similar organization with the histone H3
protein [6,15,16]. The high degree of sequence identity seen
between CENP-A and histone H3 suggests that CENP-A acts
in a certain speci¢c set of centromeric nucleosomes [9]. How-
ever, sequence analysis revealed that CENP-A possesses an N-
terminal domain divergent from that of histone H3.
In contrast to CENP-B and CENP-C, to our knowledge
CENP-A cDNA has not been expressed in Escherichia coli
systems, and monospeci¢c antibodies to this protein are not
available yet. This type of monospeci¢c probe could be val-
uable for studying the role of CENP-A in chromatin assembly
at the centromere and for a better understanding of the asso-
ciation of the protein with the active kinetochore in mitosis
and meiosis. Recently a human autoepitope on the CENP-A
molecule has been indicated in a large number of CREST
patients showing anti-centromere antibodies [17].
In this report, we describe for the ¢rst time a novel centro-
mere serum to CENP-A generated in vitro against an N-ter-
minal peptide of the CENP-A molecule. Our results indicate
conservation of a human CENP-A autoepitope in other mam-
malian centromeres analyzed. Thus, CENP-A seems to play a
universal role at the structure of mammalian centromeric
chromatin organization.
2. Materials and methods
2.1. Reagents
Peroxidase-conjugated goat anti-rabbit IgG and £uorescein-conju-
gated goat anti-rabbit IgG were from Boehringer Mannheim Bio-
chemicals (Germany); anti-Fas serum was kindly provided by Dr.
JoseŁ Brieva of the Puerta del Mar Hospital, in CaŁdiz; nitrocellulose
blotting membranes (0.45 Wm) were from Millipore (Bedford, MA,
USA). DMEM and fetal calf serum were from BIO-Whitakker (Bel-
gium). All other reagents were of analytical grade from Sigma.
2.2. Cell culture
HeLa, Indian muntjac and Jurkat cells were grown in DMEM/10%
fetal calf serum in coverslips until 75% con£uence before being used
for immuno£uorescence. When needed, anti-FAS/APOI serum was
used to induce apoptosis in Jurkat cells for 3^6 h before immuno-
£uorescence analysis.
2.3. Peptide synthesis and antibody production
Rabbit polyclonal antibodies were raised against the synthetic pep-
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tide PRRRSRKPEAPRRRS which corresponds to the N-terminal
amino acid sequence (residues 3^17) of human CENP-A. This peptide
was described by Muro et al. as a human autoepitope in centromere
reactive sera [17]. A carboxy-terminal cysteine was added to the pep-
tide for sulfhydryl coupling. Conjugation of the peptide to keyhole
limpet hemocyanin (KLH) was performed as described [18]. The rab-
bit antibodies were generated by Eurogentec (Belgium).
2.4. Immuno£uorescence
Culture cells were ¢xed and permeabilized in pure methanol at
320‡C for 10 min and incubated with the primary anti-CENP-A anti-
body (dilution 1:400) in PBS for 30 min at 37‡C. Thereafter, cells
were washed three times with PBS and incubated for 30 min at 37‡C
with the secondary antibody £uorescein-conjugated goat anti-rabbit
IgG (dilution 1:80) in PBS. Cells were washed three times with PBS,
counterstained with DAPI (4P,6-diamidino-2-phenylindole, Sigma)
(0.5 Wg/ml) for DNA and mounted with PBS:glycerol (1:9). Images
were taken using a Zeiss Axiophot £uorescence microscope. Jurkat
cells were used for immuno£uorescence, at time 0 and 6 h after in-
duction to apoptosis with anti-Fas serum (100 ng/ml) [19].
2.5. Immunoblot analysis
Preparation of human placenta nuclear proteins was a modi¢cation
of a previous method [4]. Brie£y, human placenta tissue was cut with
scissors into small pieces in TBS solution (10 mM Tris-HCl pH 8.0,
100 mM NaCl) containing a protease inhibitor cocktail (Boehringer
Mannheim, Germany) (TBS bu¡er). Nuclei were isolated after a brief
homogenization in a Dounce, by using 1% Triton X-100 (Sigma) in
TBS bu¡er, followed by a centrifugation step at 3000 rpm for 10 min
at 4‡C. Isolated nuclei were incubated with micrococcal nuclease
(Boehringer Mannheim) (200 units/ml) in TBS bu¡er containing 1
mM CaCl2 for 30 min at 4‡C. After a short centrifugation at 10 000
rpm for 10 min at 4‡C, the nucleus material was incubated with
heparin (1 mg/ml) (Sigma) in TBS bu¡er containing 2 mM EDTA
for 30 min at 4‡C. After a further centrifugation step the digested
nucleus material was sonicated and stored like the rest of extracted
protein samples until used, at 380‡C. The extracts were resolved in a
15% SDS-polyacrylamide gel [20] and then transferred to nitrocellu-
lose membrane in 25 mM Tris base, 180 mM glycine containing 10%
methanol (v/v) for 90 min with a constant current of 250 mA [21].
Membranes were blocked with 5% non-fat dry milk in TBS for 3 h at
room temperature, and incubated with antibodies overnight at room
temperature. Human CREST serum was used at 1:400 dilution and
rabbit anti-CENP-A at 1:500 dilution in PBS.
Detection of peroxidase-labelled secondary antibodies was done
with chloronaphthol.
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Fig. 1. Immuno£uorescence staining of HeLa and Indian muntjac culture cells with speci¢c anti-peptide CENP-A serum. Staining is restricted
in human and deer cells to uniform dots at the centromeres. HeLa cells are stained in the interphase (a), metaphase (c), and telophase (e)
stages of the cell cycle. The human CENP-A epitope is conserved in deer centromeres, as shown by staining with anti-peptide CENP-A anti-
body in interphase (b), metaphase (d) and anaphase Indian muntjac cells (f). Magni¢cation 100U.
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3. Results and discussion
3.1. Production of monospeci¢c anti-CENP-A antibody
Although human CREST autoantibodies have been useful
tools for centromere studies, monospeci¢c immunoglobulins
to each centromeric component are recommended to assign
speci¢c functions to each centromere antigen. Anti-CENP-B
and anti-CENP-C sera are available from several laboratories
[5,22^24]. However, monospeci¢c anti-CENP-A antibodies
are not available yet. Probably the main obstacles for raising
antibodies to CENP-A are the di⁄culty in achieving a signi¢-
cant expression of the cDNA in E. coli systems and, addition-
ally, the di⁄culty in purifying the native protein in su⁄cient
quantity for immunization. Also, the high sequence conserva-
tion of the protein could be an extra impediment to obtaining
a high and monospeci¢c immune response in immunized ani-
mals. We decided to used the strategy of making anti-peptide
antibodies to selected regions of the known human amino acid
sequence of CENP-A. Previously, following a similar strategy,
we had made monospeci¢c antibodies to several regions of the
highly conserved protein CENP-B including a human speci¢c
centromere serum [23]. Thus, this time we obtained a mono-
speci¢c serum to the N-terminal region (residues 3^17) of the
human centromeric histone H3-like protein CENP-A. This N-
terminal motif was recently identi¢ed by Muro et al. as a
target site for human autoimmune response in CREST pa-
tients [17]. As shown in Fig. 1 the rabbit anti-CENP-A serum
stained centromeres of interphase and mitotic HeLa cells (Fig.
1a,c,e). The staining showed a uniform punctate focus in each
centromere, similar to that described previously for human
autoantibodies [1]. However, when analyzed more precisely,
the CENP-A staining pattern clearly showed a di¡erent dis-
tribution over the surface area of the centromeric region from
that described for other centromeric autoantigens. In partic-
ular, CENP-B is usually distributed in heterogeneous areas of
the centromere, with array-like appearance, by immuno£uo-
rescence, re£ecting the centromeric heterochromatin organiza-
tion in each particular chromosome ([23,24] and data not
shown). Double immuno£uorescence analysis with human se-
rum con¢rmed that CENP-A distribution covers a more re-
stricted area on the centromere than other autoantigens (data
not shown). This result should be clari¢ed by more precise
electron microscopy studies. Although the anti-CENP-A se-
rum was generated against a human peptide antigen, reactiv-
ity was found in other mammalian cells analyzed, such as the
deer culture cells from Indian muntjac (Fig. 1b,d,f). The stain-
ing pattern in this case was as predicted, speci¢c to the cen-
tromere region of the unique chromosome set of this species
in both interphase and mitotic cells. Surprisingly, this anti-
CENP-A serum did not stain centromeres of mouse origin
(3T3 cells) and only reacted very slightly with those from
hamster (CHO cells), by immuno£uorescence (data not
shown). This agrees with a report by Sullivan et al. [13] in
which it was reported that human a⁄nity-puri¢ed autoanti-
bodies to CENP-A did not recognize rat or chicken centro-
meres, by immuno£uorescence or immunoblots. These pre-
vious data and our observations raise the possibility that
CENP-A as a histone-speci¢c protein associated with the cen-
tromeres may not be as highly conserved throughout evolu-
tion as originally predicted [15].
Our immunoblot analysis in Fig. 2 shows that anti-CENP-
A monospeci¢c serum recognizes a 17 kDa polypeptide solu-
bilized after chromatin extraction. These results indicate that
CENP-A behaves like the core histones after the extraction of
placenta nuclear proteins with nuclease and heparin, condi-
tions known to free chromatin-associated components. De-
tailed biochemical studies centered on the role of CENP-A
in the assembly of centromeric nucleosomes could now be
undertaken by purifying native CENP-A from extracted chro-
matin, using a puri¢cation scheme including speci¢c CENP-A
a⁄nity columns.
3.2. PRRRSRKPEAPRRRS is a major CENP-A autoepitope
in humans
To demonstrate that the anti-peptide CENP-A serum spe-
ci¢cally recognizes a human autoepitope, we did immunoblot
analysis on KLH-conjugated CENP-A peptide with several
human CREST sera. As shown in Fig. 3, three di¡erent hu-
man anti-centromere sera react with the KLH-conjugated
CENP-A peptide (Fig. 3B, lanes 1,3,6) as did the rabbit
anti-CENP-A monospeci¢c serum (Fig. 3B, lane 9). However,
other high titer human centromere sera apparently do not
recognize the N-terminal epitope of CENP-A tested (Fig.
3B, lanes 2,4,5). Because these sera react with the 17 kDa
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Fig. 2. Solubilization of CENP-A from human placenta nuclei. Coo-
massie blue staining of protein extracts of human nuclei after suc-
cessive incubation with microccocal nuclease (A, lane 1), heparin
(A, lane 2) and a ¢nal sonication step (A, lane 3) are shown. B: Im-
munoblot analysis of the protein extracts shown in A with anti-
CENP-A-speci¢c antibody. The arrow in B indicates the 17 kDa
centromere CENP-A polypeptide which is released from placenta
nuclei, together with the core histones shown in A. Lane M in A in-
dicates molecular weight markers, 96, 68, 50, 36, 30 and 16 kDa.
Fig. 3. The N-terminal residues 3^17 of CENP-A represents a hu-
man autoepitope recognized by some CREST sera. The CENP-A
peptide conjugated to KLH (Coomassie blue in A, lane P) was
tested by immunoblot against several human autoimmnune sera. B:
CREST sera numbers 1, 3 and 6 react with the CENP-A epitope
but not CREST sera 2, 4 and 5. Reactivity of rabbit monospeci¢c
serum to CENP-A is shown in lane 9. Two non-CREST human
sera are shown in B, lanes 7 and 8. Molecular weight protein
markers are shown in lane M.
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polypeptide on immunoblots, it could be concluded from
these data that the immune response to CENP-A in humans
includes the 3^17 epitope residues, but not exclusively. Con-
trols with other human autoantibodies demonstrated the spe-
ci¢city of the immunoblot assay for CENP-A (Fig. 3B, lanes
7,8). This result unequivocally demonstrated that the residues
3^17 on the N-terminal region of CENP-A constituted a pu-
tative linear epitope on the molecule, and represent a target of
the human autoimmune response to the centromere in a large
number of CREST patients, as indicated recently [17].
3.3. Localization of CENP-A in apoptotic cells
The mechanisms of autoimmunity are not known. A new
hypothesis for autoimmune responses to cellular damage and
apoptosis was proposed recently [25]. As has been reported, in
some cases, human autoimmune antigens are described as
having been relocated or proteolytically cleaved during apop-
tosis. This phenomenon on cell antigens could play some role
in the autoimmune response [25]. In contrast, other autoan-
tigens do not show any observable e¡ect regarding their local-
ization during in vitro induced apoptosis. To ¢nd out the
distribution of CENP-A in apoptotic cells, we did immuno-
localization of this histone-like centromere protein on Jurkat-
induced cells. Our results in Fig. 4 clearly indicate that speci¢c
staining of CENP-A on uninduced and 6 h induced cells
showed a similar pattern at the centromere. This result sug-
gests that CENP-A belongs to the group of those autoanti-
gens with unmodi¢ed localization during apoptosis, in con-
trast with other nuclear components such as UBF and RNA
polymerase I [25]. These and other speci¢c autoantigens are
apparently target substrates for several caspases activated dur-
ing early stages of apoptosis [26^28]. This observation indi-
cates that the involvement of endogenous cleavage of some
antigens in speci¢c stages of the mechanisms for autoimmune
response in humans may be variable among di¡erent autoan-
tigens.
In conclusion, we report an anti-CENP-A antibody against
an epitope on the histone-like centromere human autoantigen.
Our study by immuno£uorescence demonstrates epitope con-
servation of this antigen throughout evolution in some mam-
mals, but not all.
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